March 23, 2020 / 8:09 PM / 15 days ago

BRIEF-Moberg Pharma Enters Financing Agreement For Further Investments In MOB-015

March 23 (Reuters) - Moberg Pharma AB (publ):

* MOBERG PHARMA ENTERS FINANCING AGREEMENT OF UP TO SEK 216 MILLION FOR FURTHER INVESTMENTS IN MOB-015

* MOBERG PHARMA AB (PUBL) - ENTERED INTO A CONVERTIBLE NOTE AGREEMENT WITH NICE & GREEN S.A.

* MOBERG PHARMA AB (PUBL) - AGREEMENT ENABLES CO TO PURSUE MOB-015 POTENTIAL IN ONYCHOMYCOSIS AND CONDUCT AN ADDITIONAL CLINICAL STUDY

* MOBERG PHARMA AB (PUBL) - N&G AGREEMENT HAS TRANCHES OF INITIALLY SEK 3 MILLION PER MONTH FOR FIRST SIX MONTHS

* MOBERG PHARMA AB (PUBL) - HAS COMMITTED TO DRAW FIRST TWO TRANCHES AND CAN THEN DECIDE IF AND WHEN REMAINING TRANCHES WILL BE DRAWN.

* MOBERG PHARMA AB (PUBL) - AGREEMENT WITH N&G ALSO CONTAINS A PROFIT SHARING PROGRAM, CONSISTING OF CASH COMPENSATION TO MOBERG Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below